Neudle.com: anticonvulsants drug interaction

Differential
(Click to cross reference)

acetaminophen

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acupuncture

acyclovir

advances in neurology

adverse drug reaction

Alzheimer's disease, treatment of

amantadine

ammonia

amphetamines

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

antibiotics, neurologic complications with

anticholinesterase

anticoagulant, complications of

anticoagulant, discontinuation

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, mechanism of action of

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

artificial intelligence

aspartate aminotransferase

atrioventricular block

autonomic dysfunction

beta adrenergic blocker

calcium antagonist, side effects of

carbamazepine

carbamazepine, controlled release

carbamazepine, toxicity

cardiovascular disease

carnitine deficiency

case studies

CAT scan, angiography

catechol-o-methyltransferase inhibitor

CD4 counts

cerebellar hemorrhage

cerebral embolism, cardiac origin

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, prevention of

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest pain

children

chiropractic manipulation

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

coronary artery disease

coronary artery spasm

cost

cost effectiveness

coumarin

creatine phosphokinase(CPK)elevated

dabigatran

delay in diagnosis

dementia, treatment of

deprenyl

depression

dexamethasone suppression test

dilantin, factors influencing metabolism of

dilantin, saliva level

dilantin, serum level

drug induced neurologic disorders

drug interactions

drug overdose

drug overdose, management of

drug withdrawal

dyskinesia

dyskinesia, drug induced

dyspepsia

Echinacea

efficacy

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

embolism, silent

emergencies, neurologic

epidemiology of neurology

epilepsy referral centers

evidence-based research

gamma amino butyric acid-mimetic drug

gangrene

gastrointestinal bleeding

gemfibrozil

gender

Generative Pretrained Transformer 4

globus pallidus, stimulation

glucose tolerance test, abnormal

headache

headache, treatment of

heart block

heart valve, prosthetic

hepatic failure

herbs

hiccoughs

histamine-2 receptor blockers

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hypotension, systemic

iatrogenic neurologic disorders

immunosuppression

inappropriate antidiuretic(A.D.H.)hormone

indinavir

INR values

insomnia

intracerebral hemorrhage

L-dopa, drug interactions with and side effects of

Lennox-Gastaut syndrome

liver function enzymes

memory, impairment of

microhemorrhage, intracerebral

migraine

migraine, prophylaxis

migraine, treatment of

misdiagnosis

modafinil

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI, abnormal

multiple sclerosis

multiple sclerosis, treatment of

myasthenia gravis, diagnosis

myasthenia gravis, misdiagnosis of

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myocardial infarction

myocardial infarction, acute

myopathy, drug-induced

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neuromuscular blockade

neuropharmacology

neurotoxin

neutropenia

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

number needed to treat

old age, neurology of

omeprazole

opsoclonus

oral contraceptives

organ transplantation

orthostatic hypotension

pain, management of chronic

parietal lobe, lesion of

Parkinson disease

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinsonism syndrome

paroxetine

patient information and support

peripheral pulse, absent

platelet inhibiting drugs

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

prognosis

propoxyphene

protease inhibitor, HIV-1

proton pump inhibitors

psychosis

psychosis, acute

ptosis

pupil, dilated, bilateral

respiratory paralysis, pharmacologic

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, neonatal

seizure, non-treatment of

seizure, paradoxical

seizure, pregnancy

seizure, prognosis in adults

seizure, psychomotor-temporal lobe

seizure, remission

seizure, surgical treatment of

seizure, systemic disease causing

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, women

selective serotonin reuptake inhibitors

serum alanine aminotransferase

sleep pathology and physiology

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

spasticity

spasticity, treatment of

spina bifida

spinal cord, injury of

St. John's wort

statin therapy

statin therapy, discontinuation

statin therapy, dose

status epilepticus

status epilepticus, nonconvulsive

stimulation, deep brain

temporal lobe, status

teratogenesis

teratogenic drugs

tetrahydroaminoacridine

thrombotic thrombocytopenia purpura

transient ischemic attack

trazodone

treatment of neurologic disorder

tremor

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, treatment of

triglycerides

triptans

ultrasonography

ultrasonography, head, fetus-neonate

uremia

urine, dark

vagus nerve stimulation

venous thrombosis, non-cerebral

voice, abnormality of

Showing articles 50 to 100 of 6765 << Previous Next >>

Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998

Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998

Gabapentin Does Not Interact with a Contraceptive Regimen of Norethindrone Acetate and Ethinyl Estradiol
Neurol 50:1146-1148, Eldon,M.A.,et al, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998

Tiagabine
Lancet 351:203-207, Leach,J.P.&Brodie,M.J., 1998

Lamotrigine for Generalized Seizures Associated with the Lennox-Gestaut Syndrome
NEJM 337:1807-1812, Motte,J.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997

The Clinical Relevance of the Interaction Between Carbamazepine and Dextropropoxyphene in Elderly Patients in Gotenburg, Sweden
Europ J Clin Pharm 53:203-206, Bergendal,L.,et al, 1997

Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Gabapentin Interaction with Felbamate
Neurol 47:1106, Hussein,G.,et al, 1996

Antiepileptic Medication and Oral Contraceptive Interactions:A National Survey of Neurologists and Obstetricians
Neurol 46:1534-1539, Krauss,G.L.,et al, 1996

New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996

Ticlopidine Impairs Phenytoin Clearance:A Case Report
Neurol 46:1172-1173, Riva,R.,et al, 1996

Riluzole
Lancet 348:795-799, Wokke,J., 1996

Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction
Arch Neurol 53:1191-1192, Privitera,M.&Welty,T.E., 1996

Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Tacrine
Lancet 345:625-630, Davis,K.L.&Powchik,P., 1995

Serotonin Syndrome
Neurol 45:219-223, Bodner,R.A.,et al, 1995

Gabapentin
Lancet 343:89-91, Chadwick,D., 1994

Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994

Gabapentin-A New Anticonvulsant
The Medical Letter, 36:39-401994., , 1994

Risperidone
Lancet 343:457-460, Livingston,M.G., 1994

Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994

Felbamate
The Medical Letter 35:107-109, , 1993

Felbamate:A New Antiepileptic Drug
Lancet 341:1445-1446, Brodie,M.J., 1993

Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993

Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993

Phenytoin
BMJ 305:1215-1218, Aronson,J.K.,et al, 1992

Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992

Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992

Lamotrigine
Lancet 339:1397-1400, Brodie,M.D., 1992

Toxic Reaction Following the Combined Administration of Fluoxetine and Phenytoin:Two Case Reports
JNNP 55:412-413, Jalil,P., 1992

Erythromycin and Valproate Interaction
Ann Int Med 116:877-878, Redington,K.,et al, 1992

Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992

Phenytoin and Carbamazepine Decrease Oral Bioavailability of Praziquantel
Neurol 42:492-496, Bittencourt,P.R.M.,et al, 1992

Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992

Prolonged Paralysis after Treatment with Neuromuscular Junction Blocking Agents
Crit Care Med 19:1125-1131, Gooch,J.L.,et al, 1991

Severe Adverse Interaction Between Pethidine and Selegiline
Lancet 337:246, Zornberg,G.L.,et al, 1991

Oral Anticoagulant Drugs
NEJM 324:1865-1875, Hirsh,J., 1991

Interactions Between Calcium Channel Blockers and the Anticonvulsants Carbamazepine and Phenytoin
Neurol 41:740-742, Bahls,F.H.,et al, 1991

The Effect of Valproic Acid on Plasma Carnitine Levels
Am J Dis Child 145:9999-1001, Opala,G.,et al, 1991

Showing articles 50 to 100 of 6765 << Previous Next >>